The FDA revoked the emergency use authorization for Chloroquine and Hydroxychloroquineare, except in the context of a clinical trial. Recommendations are against the use of lopinavir/ritonavir or other HIV protease inhibitors, unfavorable pharmacodynamics and clinical trials have not demonstrated a clinical benefit. The use of tocilizumab in combination with dexamethasone is recommended in certain hospitalized patients. There are insufficient data to recommend either for or against the use of convalescent plasma.
SNOMED_CT Problem=191415002 (PB0050); SNOMED_CT Cat-Tar=409022004 (CG0003, TG0073)